Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133

Liu, YHA; Jin, QH; Zou, YF; Ding, Q; Yan, SS; Wang, ZC; Hao, XS; Nguyen, B; Zhang, XY; Pan, JF; Mo, TT; Jacobsen, K; Lam, T; Wu, TYH; Petrassi, HM; Bursulaya, B; DiDonato, M; Gordon, WP; Liu, B; Baaten, J; Hill, R; Van, NT; Qiu, MH; Zhang, YQ; Kamireddy, A; Espinola, S; Deaton, L; Ha, S; Harb, G; Jia, Y; Li, J; Shen, WJ; Schumacher, AM; Colman, K; Glynne, R; Pan, SF; McNamara, P; Laffitte, B; Meeusen, S; Molteni, V; Loren, J

Loren, J (corresponding author), Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA.

JOURNAL OF MEDICINAL CHEMISTRY, 2020; 63 (6): 2958